Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users

Contraception

Volumn 70, Issue 4, 2004, Pages 277-279

  Tantiwattanakul, Pisit ^a   Taneepanichskul, Surasak ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Depot medroxyprogesterone acetate; Mefenamic acid

Indexed keywords

MEDNIL; MEDROXYPROGESTERONE ACETATE; MEFENAMIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPEPSIA; FEMALE; FOLLOW UP; HUMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPOTTING; STATISTICAL SIGNIFICANCE; UTERUS BLEEDING;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONTRACEPTIVE AGENTS, FEMALE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MEFENAMIC ACID; PLACEBOS; UTERINE HEMORRHAGE;

EID: 4644293590     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.04.003     Document Type: Article

References (16)

1. Taneepanichskul S., Reinprayoon D., Phaosavadi S. DMPA use above the age of 35 in Thai women. Contraception. 61:2000;281-282
2. Chotnopparatpattara P., Taneepanichskul S. Use of depot medroxyprogesterone acetate in Thai adolescents. Contraception. 62:2000;137-140
3. Lockwood C.J., Runic R., Wan L., Krikun G., Demopolous R., Schatz F. The role of tissue factor in regulating endometrium haemostasis implications for progestin-only contraception. Hum Reprod. 15:(Suppl 3):2000;144-151
4. Subakir S.B., Abdul Maduid O., Sabariah S., Affandi B. Oxidative stress, vitamin E and progestin breakthrough bleeding. Hum Reprod. 15:(Suppl 3):2000;18-23
5. Frasor I.S., Hickey M. Endometrial vascular change and bleeding disturbance with long-acting progestin. Steroids. 65:2000;665-670
6. Mitchell M.D. Reproductive roles of eicosamoids. Adashi E.Y., Rock J.A., Rosenwaks Z. Reproductive endocrinology, surgery and technology. 1996;841-858 Lippincott-Raven, Philadelphia
7. Speroff L., Glass R.H., Kase N.G. Clinical gynecologic endocrinology and infertility. 6th ed :1999;Williams & Wilkins, Baltimore (MD)
8. Bonnar J., Sheppard B.L. Treatment of menorrhagia during menstruation randomised control trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ. 313:1996;579-582
9. Van Eijkeren M.A., Christiaens G.C., Geuze H.J., Haspels A.A., Sixma J.J. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. Am J Obstet Gynecol. 166:1992;1419-1428
10. Chamberlain G., Freeman R., Price F., Kennedy A., Green D., Eve L. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. Br J Obstet Gynaecol. 98:1991;707-711
11. Grover V., Usha R., Gupta U., Kalra S. Management of cyclical menorrhagia with prostaglandin synthetase inhibitor. Asia Oceania Obstet Gynecol. 16:1990;255-259
12. Mukherjea M., Mukherjee P., Biswas R. Long-term contraception with Depo-Provera clinical evaluation. Int J Fertil. 25:1980;122-126
13. White J.O., Sullivan M.H.F., Patel L., et al. Prostaglandin production in human endometrium following continuous exposure to low dose levonorgestel released from a vaginal ring. Contraception. 43:1991;401-412
14. Elder M.G., Patel L., White O.J. Effects of contraceptive progestrogens on prostaglandins. d'Arcangues C., Fraser I.S., Newton J., Odlind V. Contraception and mechanisms of endometrial bleeding. 1990;279-287 Cambridge University Press, Cambridge
15. Lora M., Denault J.B., Leduc R., de Brum-Fernandes A.J. Systematic pharmacological approach to the characterization of NSAIDs. Prostaglandins Leukot Essent Fatty Acids. 59:1998;55-62
16. Kaewrudee S., Taneepanichskul S., Jaisamran U., Reinprayoon D. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use. Contraception. 60:1999;25-30